These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10199583)

  • 1. Inhibition of aldose reductase in human erythrocytes by vitamin C.
    Vincent TE; Mendiratta S; May JM
    Diabetes Res Clin Pract; 1999 Jan; 43(1):1-8. PubMed ID: 10199583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin C: an aldose reductase inhibitor that normalizes erythrocyte sorbitol in insulin-dependent diabetes mellitus.
    Cunningham JJ; Mearkle PL; Brown RG
    J Am Coll Nutr; 1994 Aug; 13(4):344-50. PubMed ID: 7963139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human erythrocyte recycling of ascorbic acid: relative contributions from the ascorbate free radical and dehydroascorbic acid.
    May JM; Qu ZC; Cobb CE
    J Biol Chem; 2004 Apr; 279(15):14975-82. PubMed ID: 14752116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-dependent ascorbate recycling in human erythrocytes: role of thioredoxin reductase.
    Mendiratta S; Qu ZC; May JM
    Free Radic Biol Med; 1998 Jul; 25(2):221-8. PubMed ID: 9667500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro retinal and erythrocyte polyol pathway regulation by hormones and an aldose reductase inhibitor.
    Hotta N; Kakuta H; Koh N; Fukasawa H; Yasuma T; Awaya S; Sakamoto N
    Diabetes Res Clin Pract; 1991 Oct; 14(1):29-35. PubMed ID: 1748061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by ascorbic acid. An effect mediated by the free radical monodehydroascorbate.
    Harwood HJ; Greene YJ; Stacpoole PW
    J Biol Chem; 1986 Jun; 261(16):7127-35. PubMed ID: 3711081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycemia-induced activation of human erythrocyte aldose reductase and alterations in kinetic properties.
    Srivastava SK; Ansari NH; Hair GA; Jaspan J; Rao MB; Das B
    Biochim Biophys Acta; 1986 Mar; 870(2):302-11. PubMed ID: 3082363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of aldose reductase inhibitor (ONO-2235) on human erythrocyte sorbitol concentrations in 75 g oral glucose tolerance tests.
    Kamon N; Mabuchi H; Takeda R; Terashima H
    Horm Metab Res; 1991 May; 23(5):226-9. PubMed ID: 1908433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated and unactivated forms of human erythrocyte aldose reductase.
    Srivastava SK; Hair GA; Das B
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7222-6. PubMed ID: 3933003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crucial role of aldose reductase activity and plasma glucose level in sorbitol accumulation in erythrocytes from diabetic patients.
    Hamada Y; Kitoh R; Raskin P
    Diabetes; 1991 Oct; 40(10):1233-40. PubMed ID: 1936586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological properties of fidarestat, a potent aldose reductase inhibitor, clarified by using sorbitol in human and rat erythrocytes.
    Sobajima H; Aoki T; Sassa H; Suzuki T; Taniko K; Makino M; Mizuno K; Suzuki T
    Pharmacology; 2001 May; 62(4):193-9. PubMed ID: 11359994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental and clinical studies on the reduction of erythrocyte sorbitol-glucose ratios by ascorbic acid in diabetes mellitus.
    Wang H; Zhang ZB; Wen RR; Chen JW
    Diabetes Res Clin Pract; 1995 Apr; 28(1):1-8. PubMed ID: 7587907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of aldose reductase in rat lens and metal-ion chelation by aldose reductase inhibitors and lipoic acid.
    Ou P; Nourooz-Zadeh J; Tritschler HJ; Wolff S
    Free Radic Res; 1996 Oct; 25(4):337-46. PubMed ID: 8889497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
    Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
    Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reduction of erythrocyte sorbitol by ascorbic acid in patients with diabetes mellitus].
    Wang H; Zhang ZB; Wen RR
    Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):548-51, 583. PubMed ID: 7842354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sorbinil and ascorbic acid on myo-inositol transport in cultured rat Schwann cells exposed to elevated extracellular glucose.
    Karihaloo AK; Joshi K; Chopra JS
    J Neurochem; 1997 Nov; 69(5):2011-8. PubMed ID: 9349546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microdetermination of aldose and aldehyde reductases from human tissues.
    Song HP; Das B; Srivastava SK
    Curr Eye Res; 1987 Aug; 6(8):1001-6. PubMed ID: 3117493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of sorbitol formation in human erythrocytes by calcium dobesilate.
    Schmidt M; Michal M
    Arzneimittelforschung; 1989 Apr; 39(4):493-5. PubMed ID: 2502128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocytic sorbitol contents in diabetic patients correlate with blood aldose reductase protein contents and plasma glucose levels, and are normalized by the potent aldose reductase inhibitor fidarestat (SNK-860).
    Asano T; Saito Y; Kawakami M; Yamada N; Sekino H; Hasegawa S;
    J Diabetes Complications; 2004; 18(6):336-42. PubMed ID: 15531183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of ascorbic acid recycling in human erythrocytes.
    May JM; Qu Z; Morrow JD
    Biochim Biophys Acta; 2001 Oct; 1528(2-3):159-66. PubMed ID: 11687303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.